ArticleJournal for immunotherapy of cancer2023

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.

Aimilia Schina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.